Which startups have raised the most funding in the remote patient monitoring market?

Last updated: 13 July 2026

A constantly refreshed list of the top startups in the remote patient monitoring market, ranked by cumulative funding raised

market research pitch 2026

In our updated market reports, you will find everything you need

The remote patient monitoring market is becoming one of the most important parts of digital health, as providers, payers, and patients look for better ways to manage chronic conditions outside the clinic.

This list ranks the top remote patient monitoring startups by cumulative funding raised, and we update it every month to keep the dataset fresh.

The ranking includes diabetes care, cardiac monitoring, virtual wards, wearable biosensors, chronic care platforms, and hospital-at-home monitoring companies.

A quick summary table

Metric Value
Most funded startup Beta Bionics, $570M raised
Second most funded startup Omada Health, $542M raised
Largest funding round Oviva, $220M Series D in January 2026
Median funding $40M
Share of funding captured by the top 10 About 45.7%
Median time since last round About 33 months
Startups that raised funding in the last 12 months 22 startups
Remote patient monitoring startups tracked 91 startups
Remote patient monitoring companies with IPO status 8 companies
Remote patient monitoring companies acquired 12 companies

Top startups in the remote patient monitoring market ranked by total funding raised

Here is an updated table that ranks the top startups in the remote patient monitoring market based on the total amount of funding they have raised to date.

The table also includes the total number of funding rounds, the date and size of the latest round, the financing type, key investors, the startup’s current status, and a confidence score based on the data collected.

# Startup What They Do Total Raised ($) Total Rounds Last Round Date Last Round Amount ($) Last Round Type Key Investors Current Stage Confidence
1 Beta Bionics Automated insulin delivery $570M 7 January 2025 $17M PIPE / Private Placement Wellington Management, Sands Capital, Omega Funds IPO Strong
2 Omada Health Virtual chronic care programs $542M 8 June 2025 $150M IPO Fidelity, aMoon, Wellington Management IPO Strong
3 Biofourmis AI-enabled remote care platform $461M 6 August 2022 $20M Series D extension Intel Capital, General Atlantic, CVS Health Active Strong
4 Virta Health Diabetes reversal virtual care $402M 7 December 2025 $30M Series F Tiger Global, Sequoia, Caffeinated Capital Active Strong
5 Huma Digital health monitoring platform $355M 13 April 2025 $17M Series D / late-stage AstraZeneca, Hitachi Ventures, Leaps by Bayer Active Partial
6 Oviva Digital chronic care $335M 4 January 2026 $220M Series D Kinnevik, Planet First Partners, A.P. Moller Holding Active Strong
7 Senseonics Implantable glucose monitoring $289M 5 May 2026 $92M Public Offering NEA, Delphi Ventures, Anthem Capital IPO Partial
8 Twin Health Metabolic digital twins $283M 5 August 2025 $53M Series E Maj Invest, ICONIQ Capital, Temasek Active Strong
9 Athelas Remote care and healthcare AI $276M 6 May 2026 $70M Growth financing General Catalyst, Sequoia Capital, Morgan Stanley Active Partial
10 Biolinq Wearable metabolic biosensors $273M 5 April 2025 $100M Series C Alpha Wave Ventures, RiverVest, AXA IM Alts Active Strong
11 DarioHealth Chronic-condition digital care $269M 26 September 2025 $18M Post-IPO Private Placement Existing shareholders, healthcare investors IPO Partial
12 Cadence Chronic care at home $241M 3 June 2026 $100M Series C Spark Capital, Thrive Capital, General Catalyst Active Full
13 VitalConnect Wearable biosensor patient monitoring $240M 6 February 2025 $100M Undisclosed / mixed equity-debt Ally Bridge Group, EW Healthcare Partners, MVM Active Partial
14 FIRE1 Heart failure monitoring device $227M 6 January 2025 $120M Series D Polaris Partners, Elevage Medical Technologies, Sands Capital Active Strong
15 Glooko Diabetes data platform $201M 8 October 2024 $100M Series F Georgian, Health Catalyst Capital, Canaan Active Strong
16 Lark Health AI chronic disease coaching $170M 5 October 2021 $100M Series D Deerfield Management, PFM Health Sciences, Franklin Templeton Active Partial
17 Eko Health AI cardiac stethoscope platform $165M 7 June 2024 $41M Series D ARTIS Ventures, Highland Capital Partners, NTTVC Active Strong
18 Bigfoot Biomedical Smart insulin systems $149M 4 June 2020 $55M Series C Abbott, Quadrant Capital Advisors, Janus Henderson Acquired Partial
19 BioIntelliSense Medical-grade wearable patient monitoring $140M 4 December 2025 $58M Series C Chimera Investments, Philips, Fresenius Active Strong
20 Preventice Solutions Remote cardiac monitoring services $138M 7 July 2020 $137M Series B Vivo Capital, Novo Holdings, Merck GHI Acquired Partial
21 Hello Heart Digital heart health therapeutics $138M 4 December 2023 $70M Series D Stripes, IVP, Khosla Ventures Active Strong
22 InfoBionic Cardiac remote monitoring platform $135M 7 September 2023 $58M Series D Security International Investments, Mayo Clinic, Excel Venture Management Active Partial
23 AliveCor Personal ECG monitoring devices $134M 7 August 2022 Undisclosed Series F GE Healthcare, Khosla Ventures, Qualcomm Ventures Active Partial
24 Diabeloop AI insulin delivery $125M 4 March 2024 $16M Venture / Growth Equity LBO France, Terumo, Innovacom Active Partial
25 Electronic Caregiver AI virtual care monitoring platform $110M 5 June 2025 Undisclosed Series D / later-stage NM Vintage Fund, repeat investors Active Partial
26 Endotronix Heart failure pressure monitoring $102M 2 October 2019 $70M Series D LSP, Lumira Ventures, SV Health Investors Acquired Partial
27 iRhythm Technologies Wearable cardiac rhythm analytics $99M 10 May 2014 $17M Series E Novo A/S, Norwest Venture Partners, New Leaf Ventures IPO Partial
28 Bardy Diagnostics Ambulatory cardiac monitor patch $83M 4 February 2020 $13M Series B extension River Cities, HealthQuest Capital, Lumira Ventures Acquired Partial
29 Sidekick Health Digital therapeutics platform $77M 3 May 2022 $55M Series B Novator Ventures, Wellington Partners, Asabys Partners Active Strong
30 Sibel Health Wireless wearable vital-sign monitoring $72M 2 October 2025 $9M Series C extension Steele Foundation, Dräger, Samsung Next Active Strong
31 Podimetrics Diabetic foot monitoring $72M 5 March 2022 $45M Series C D1 Capital Partners, Medtech Convergence Fund, Polaris Partners Active Partial
32 Current Health Hospital-at-home monitoring platform $66M 5 April 2021 $43M Series B Northpond Ventures, LRVHealth, OSF HealthCare Active Strong
33 Doccla Virtual ward monitoring services $65M 3 August 2024 $45M Series B Lakestar, General Catalyst, Speedinvest Active Full
34 CoachCare RPM and virtual care management $60M 4 February 2025 $1M Late-stage / undisclosed Catalyst Investors, Integrity Growth Partners, Topmark Partners Active Partial
35 TimeDoc Health Virtual chronic care management $58M 4 March 2022 $49M Series B Aldrich Capital, Vocap, Grand Ventures Active Strong
36 Glytec Diabetes insulin management software $56M 3 June 2025 $36M Series C / Growth Savitr Capital, Hayfin Capital Management Active Partial
37 Indigo Diabetes Implantable glucose sensor $53M 2 July 2020 $45M Series B Fund+, Ackermans & van Haaren, imec.xpand Active Full
38 Cecelia Health Virtual chronic care platform $52M 11 June 2025 $16M Series D / Later-stage SJF Ventures, Rittenhouse Ventures, Croft & Bender Active Partial
39 Biobeat Cuffless blood pressure monitoring $51M 2 December 2025 $50M Series B Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies Active Strong
40 BeatO Smartphone diabetes care app $51M 12 April 2023 $171K Series B extension / bridge Lightrock India, HealthQuad, Flipkart Ventures Active Strong
41 HealthSnap RPM and chronic care platform $49M 6 February 2024 $25M Series B Sands Capital, Comcast Ventures, Florida Funders Active Strong
42 Casana Smart toilet health monitoring $46M 3 January 2022 $30M Series B Morningside, General Catalyst, Matrix Active Strong
43 Medical Informatics Corp ICU data and virtual care $45M 5 December 2024 $5M Early/other equity Catalio, Intel Capital, DCVC Active Partial
44 CarePredict AI senior care monitoring $42M 8 September 2024 $4M Series A extension SV Health Investors, Aspire, Las Olas Active Partial
45 Nutromics Wearable continuous diagnostic monitoring $40M 6 September 2025 $5M Series A / Acceleration Dexcom Ventures, VU Venture Partners, Artesian Active Strong
46 Optimize Health Remote care management platform $40M 4 October 2023 $18M Series B Foundry, Escalate Capital Partners, Bonfire Ventures Active Strong
47 100Plus Remote monitoring for Medicare patients $39M 8 March 2021 $25M Seed Henry Kravis, George Roberts, Tony Robbins Acquired Partial
48 Cardiac Insight Wearable ECG analysis devices $37M 13 February 2020 $8M Series D SeaChange Fund, Welch Allyn, WRF Capital Acquired Partial
49 Validic Health data connectivity platform $32M 8 November 2022 $12M Series B extension Kaiser Permanente Ventures, Greycroft, SJF Ventures Acquired Strong
50 9am.health Virtual cardiometabolic clinic $29M 3 February 2024 $10M Series A extension Cigna Ventures, 7wireVentures, Define Ventures Active Full
51 Neteera Contactless vital-sign monitoring $28M 3 October 2023 $7M Series B extension Aescuvest, Foxconn Technology, Omega Healthcare Investors Active Full
52 Implicity Remote cardiac monitoring platform $28M 3 April 2022 $23M Series A Crédit Mutuel Innovation, Bpifrance, BNP Paribas Développement Active Strong
53 Sugar.fit Diabetes reversal programs $27M 4 April 2025 $1M Angel / extension MassMutual Ventures, Cure.fit, Endiya Partners Active Partial
54 Qardio Connected heart monitoring devices $27M 4 Undisclosed Undisclosed Series A / growth equity Elysia Capital, Eastbourne Investment Group, Medical Technology Venture Partners Active Partial
55 Dozee Contactless patient monitoring system $25M 5 April 2026 Undisclosed Series A Prime Venture Partners, 3one4 Capital, YourNest Active Partial
56 GraphWear Needle-free glucose wearable $25M 5 October 2021 $21M Series B Mayfield, MissionBio Capital, Builders VC Active Strong
57 Siren Care Diabetic foot monitoring socks $25M 4 January 2025 $10M Strategic equity Mölnlycke Health Care, Khosla Ventures, DCM Active Strong
58 Sweetch AI chronic-care engagement $24M 2 July 2021 $20M Series A Entrée Capital, Tal Capital, Noaber Active Partial
59 Somatix Wearable AI patient monitoring $23M 6 November 2024 $1M Series A extension Digitalis Ventures, Forefront Analytics Acquired Partial
60 WearLinq Wireless multi-lead ECG wearable $21M 3 December 2025 $14M Series A AIX Ventures, SpringTide, Amino Capital Active Strong
61 Fitterfly Digital diabetes therapeutics platform $19M 4 July 2022 $12M Series A Amazon Smbhav, Fireside Ventures, Venture Catalysts Acquired Strong
62 Myia Labs AI virtual care platform $17M 3 January 2021 Undisclosed Series A extension Mercy Virtual, B Capital Group, Movac Active Strong
63 Limber Health Hybrid MSK remote monitoring $16M 2 May 2024 $2M Series A extension Blue Venture Fund, Glenview Capital Acquired Strong
64 Vectorious Medical Technologies Implantable heart pressure sensor $15M 2 March 2018 $10M Series B Broadview Ventures, GEOC, Fresenius Acquired Strong
65 Murj Cardiac device management software $14M 3 May 2018 $9M Series B Longitude Capital, True Ventures, Social Capital Active Strong
66 Epitel Wearable EEG seizure monitoring $13M 2 February 2022 $13M Series A Catalyst Health Ventures, Genoa Ventures, Dexcom Active Strong
67 Vector Remote Care Cardiac device remote monitoring $13M 1 April 2021 $13M Series A Updata Partners Active Full
68 Cloud DX Virtual care RPM platform $12M 5 March 2025 Undisclosed Preferred shares planned Roosevelt Capital Group investors IPO Partial
69 Elfie Rewarded chronic-care health app $12M 2 June 2025 $12M Series A White Star Capital, LifeX Ventures, Integra Partners Active Strong
70 Assure Health Chronic care remote monitoring $11M 2 March 2022 $9M Seed Red Cell Partners, Fanjul Capital Active Partial
71 Acorai Heart failure pressure monitoring $11M 3 December 2024 $5M Seed Taipei Medical University, Solardis Health Ventures, KHP Ventures Active Partial
72 POPS! Diabetes Care Smartphone diabetes care system $10M 5 2019 Undisclosed Seed / extension 30Ventures, Rise of the Rest, Flying Point Industries Active Strong
73 MayaMD AI patient engagement assistant $9M 2 April 2022 Undisclosed Series A Lux Capital, Prospeq, LG NOVA Active Low
74 Videra Health Behavioral health video monitoring $9M 2 May 2024 $6M Seed II Peterson Ventures, Mercato Partners, EPIC Ventures Active Full
75 Ventricle Health Virtual cardiology care platform $8M 1 September 2023 $8M Seed RA Capital Management, Waterline Ventures Active Full
76 BioT Medical device cloud infrastructure $7M 2 March 2023 Undisclosed Seed extension Bridges Israel, North First Ventures, XT Venture Capital Active Partial
77 Lapsi Health Digital stethoscope biomarkers $6M 3 January 2025 $2M Seed extension Modi Ventures, Mentors Fund, 1921VC Active Strong
78 NanoVation Respiratory disease monitoring $6M 1 July 2021 $6M Series A EIC Fund Active Strong
79 Suvera Virtual chronic-care platform $5M 1 July 2022 $5M Seed extension Morningside Ventures Active Full
80 Novi Health Chronic disease care platform $5M 1 November 2022 $5M Series A Monk’s Hill Ventures Active Full
81 mySugr Diabetes management app $5M 2 March 2015 $5M Seed Roche Ventures, iSeed Ventures, XLHealth Acquired Strong
82 Habitual Type 2 diabetes reversal $4M 3 April 2025 $1M Seed extension Nesta Impact Investments, MMC Ventures, Seedcamp Active Strong
83 Oxitone Medical Wrist pulse oximetry monitoring $3M 1 September 2014 $3M Seed TMC Innovation, Saints Capital, Connecticut Innovations Active Strong
84 HealthBeats Remote vitals monitoring platform $3M 1 April 2022 $3M Seed Heritas Capital, SEEDS Capital Active Full
85 CARI Health Wearable medication monitoring $3M 3 July 2025 $100K Seed SDAC, NuFund, Cove Fund Active Strong
86 Noah Labs AI heart failure monitoring $3M 1 September 2024 $3M Seed Nina Capital, adesso ventures, Brandenburg Kapital Active Partial
87 Hop Technologies AI digital biomarkers $2M 1 Undisclosed $2M Funding Raised Iaso Ventures Active Low
88 Nemaura Medical Non-invasive glucose monitoring $2M 1 December 2018 $2M Public offering Dawson James Securities IPO Low
89 Nanowear Textile nanosensor remote diagnostics $2M 1 March 2015 $2M Seed MAS Holdings, Social Capital Active Partial
90 PharmD Live Pharmacist-led chronic care $1M 2 January 2022 $1M Seed Teladoc Health, Village Capital, 1836 Ventures Active Partial
91 Medella Health Smart glucose contact lenses $1M 2 June 2016 $1M Seed BDC, Garage Technology Ventures, 1517 Fund Active Strong

Key funding trends in the remote patient monitoring market

Insights

  • The top 10 remote patient monitoring startups raised about $3.79B, equal to nearly 46% of all funding in this dataset, so capital is highly concentrated
  • Diabetes and metabolic-care startups dominate the upper tier, with Beta Bionics, Omada Health, Virta Health, Oviva, Twin Health, Biolinq, and Glooko raising about $2.61B combined
  • The largest remote patient monitoring platforms are moving beyond devices, since companies such as Omada Health, Virta Health, Oviva, Cadence, and Hello Heart combine monitoring with ongoing care delivery
  • Recent investor appetite is still meaningful, with Oviva, Cadence, Biolinq, FIRE1, and Glooko each raising $100M or more in the latest disclosed financing
  • Cardiovascular monitoring remains a durable funding theme, with FIRE1, Eko Health, Hello Heart, BioIntelliSense, Sibel Health, Implicity, and Murj raising about $708M combined
  • Wearable biosensor startups still attract large checks, as Biolinq, BioIntelliSense, Sibel Health, Biobeat, and Nutromics raised about $576M across metabolic, cardiac, and vital-sign monitoring
  • Strategic healthcare investors appear often in the strongest remote patient monitoring companies, especially CVS Health, Philips, Dexcom, Abbott, Roche, AstraZeneca, and Bayer-linked capital
  • Acquisitions mostly happen below the largest independent platforms, with Validic, Fitterfly, Limber Health, Vectorious, mySugr, Bardy Diagnostics, and Preventice Solutions all exiting after smaller funding totals

A few word about our methodology

As you can see, we built a database that ranks startups in the remote patient monitoring market based on their total cumulative fundraising. To create this ranking, we reviewed many sources and cross-checked information across multiple places.

Whenever possible, we prioritized official company communications, since those are usually the most reliable source for funding amounts. When those were not available, we relied on reputable industry sources such as TechCrunch, Crunchbase, Financial Times, Forbes, MobiHealthNews, Fierce Healthcare, or company investor pages.

We excluded random blogs, unverified websites, and any sources that could not be validated.

When funding rounds were announced in other currencies such as euros, British pounds, Swiss francs, Singapore dollars, Australian dollars, or rupees, we converted them into approximate USD equivalents for consistency.

Sometimes different sources report slightly different numbers, or the exact round size is not fully disclosed. In those cases, we flag the uncertainty and assign a confidence label to each startup, visible in the last column.

Here is what they mean.

Full confidence: The company’s equity fundraising history can be reconstructed completely from public sources. The rounds, dates, amounts, and key investors are clearly identified, with no meaningful gaps.

Strong confidence: The fundraising history is largely complete and reliable. There may be a small missing detail, such as incomplete investor information or a minor round with limited data, but the overall record is clear.

Partial confidence: The main fundraising rounds can be identified, but the record is incomplete or somewhat mixed. Some rounds may be missing or certain funding events may be difficult to separate clearly.

Low confidence: Public information is too limited, inconsistent, or ambiguous to reliably reconstruct the company’s equity fundraising history.

When the confidence level is too low, we take a conservative approach and flag the company clearly. We don’t want readers to confuse uncertain data with fully verified funding history.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific calculation, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog